IgG N-glycosylation is not influenced by severity of complications in type 1 diabetes (CROSBI ID 735511)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa
Podaci o odgovornosti
Plavša, Branimir ; Kološnjaj, Ivona ; Bulum, Tomislav ; Tomić, Martina: Vučković Rebrina, Sandra ; Vučić Lovrenčić, Marijana ; Duvnjak, Lea ; Gornik, Olga
engleski
IgG N-glycosylation is not influenced by severity of complications in type 1 diabetes
N-glycosylation of immunoglobulin G (IgG) is known to influence the antibody function. Changes in IgG N-glycome associate with many inflammatory conditions and were reported in early stages of type 1 and type 2 diabetes mellitus (DM). IgG N- glycosylation was also studied in relation to disease progression in type 2 DM and was found to associate with diabetes complications. Although type 1 and type 2 DM share complications, these findings may not apply to type 1 DM due to different pathophysiology involved and a longer disease duration prior to complication manifestation.
glycosylation, N-glycosylation, IgG, diabetes, type 1
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
120-121.
2022.
objavljeno
Podaci o matičnoj publikaciji
Podaci o skupu
HDBMB 2022 Congress – From Science to Knowledge
poster
28.09.2022-01.10.2022
Brela, Hrvatska
Povezanost rada
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)